跳至主要内容
临床试验/NCT04102735
NCT04102735已完成不适用

UNDER the Nose vs. Over the Nose Face Mask to Prevent Facial PRESSURE Ulcers During Face Mask-noninvasive Ventilation for Acute Hypercapnic Respiratory Failure

Centre Hospitalier Arras2 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2018年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
试验地点
2
主要终点
Change of the incidence of facial pressure ulcers in the experimental arm compared to the control arm, within the first 3 days after NIV initiation.

研究概览

简要总结

Noninvasive ventilation (NIV) is essential to treat acute hypercapnic respiratory failure. However, facial pressure ulcers appearing during facemask-delivered noninvasive ventilation are a source of NIV failure by interface intolerance.

A Philips facemask (model : AF541 SE Oro-Nasal mask) has the particularity to display two options for its positioning : a usually used "over-the-nose" positioning or an "under-the-nose" positioning that is supposed to reduce the incidence of facial pressure ulcers while keeping in the same time the qualities of a standard facemask.

The goal of this controlled randomized trial is to test the hypothesis that the "under-the-nose" positioning actually reduces the incidence of facial pressure ulcers, compared to the usually used "over-the-nose" positioning.

Results of this trial should lead to the proposition of a new interface strategy to prevent facial pressure ulcers and therefore to improve the tolerance of NIV via the use of facemasks displaying an "under-the-nose" positioning.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute hypercapnic respiratory failure
  • Initiation of NIV
  • Estimated cumulative time of NIV upper than 12 hours for the first 48 hours of hospitalization

排除标准

  • Contraindication for NIV (respiratory arrest, impossibility to fit the mask)
  • Intubated patient
  • Patient with a tracheostomy
  • Post-extubation respiratory failure
  • Patient exhibiting facial ulcers or skin lesions located at the insertion points of the mask before its hospitalization
  • Person declining NIV
  • Pregnancy
  • Dying person

结局指标

主要结局

Change of the incidence of facial pressure ulcers in the experimental arm compared to the control arm, within the first 3 days after NIV initiation.

时间窗: 3 days after NIV initiation

The primary endpoint is the development of a facial pressure ulcer within the first 3 days after NIV initiation

次要结局

  • Change of the severity of facial pressure ulcers in the experimental arm, compared to the control arm(7 days after NIV initiation)
  • Change of the patient comfort in the experimental arm, compared to the control arm(24 hours after NIV initiation)
  • Change of the delay for facial pressure ulcers to appear in the experimental arm, compared to the control arm(7 days after NIV initiation)
  • Change of the incidence of mask changes related to interface intolerance in the experimental arm, compared to the control arm(7 days after NIV initiation)
  • Change of the incidence of NIV failure in the experimental arm, compared to the control arm(7 days after NIV initiation)

研究者

发起方
Centre Hospitalier Arras
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验